Exscientia (EXAI) Stock Chart & Stock Price History → How to Make 100X on the AI Boom (From InvestorPlace) (Ad) Free EXAI Stock Alerts $4.96 +0.05 (+1.02%) (As of 11:27 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Exscientia Stock Price Performance5 Day Performance-0.81%1 Month Performance+5.48%3 Month Performance-16.78%6 Month Performance-15.64%Year-To-Date Performance-23.40%1 Year Performance-6.12% Receive EXAI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Exscientia and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceElon Musk’s Next Move Will Disrupt AI ForeverA revolutionary venture that is set to get rolled out by May 16. One well-connected Silicon Valley VC has uncovered a way for anybody to claim a stake in "Elon Musk's AI 2.0" with as little as $100.Get all the information here. EXAI Stock Chart for Tuesday, May, 14, 2024 EXAI Chart by TradingView Exscientia Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/13/2024$4.61$4.91+6.51%$4.99$4.70504,790 shs$593.57 million05/10/2024$4.95$4.61-6.87%$5.00$4.57311,162 shs$557.30 million05/09/2024$4.68$4.95+5.77%$4.98$4.68263,186 shs$598.41 million05/08/2024$4.97$4.68-5.84%$4.89$4.60300,780 shs$565.77 million05/07/2024$5.00$4.97-0.60%$5.02$4.84258,713 shs$600.82 million05/06/2024$4.67$5.00+7.07%$5.01$4.61526,096 shs$604.45 million Get the Latest News and Ratings for EXAI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Exscientia and its competitors with MarketBeat's FREE daily newsletter. 05/03/2024$5.09$4.67-8.25%$5.24$4.67631,833 shs$564.56 million05/02/2024$5.14$5.09-0.97%$5.31$5.05453,821 shs$615.33 million05/01/2024$4.95$5.14+3.84%$5.23$4.71718,068 shs$621.38 million04/30/2024$4.62$4.95+7.14%$5.18$4.62707,709 shs$598.41 million04/29/2024$4.03$4.62+14.64%$4.69$4.11536,092 shs$558.51 million04/26/2024$3.99$4.03+1.00%$4.12$3.90384,641 shs$487.19 million04/25/2024$4.13$3.99-3.39%$4.13$3.86471,502 shs$482.35 million04/24/2024$4.38$4.13-5.71%$4.40$4.13364,930 shs$499.28 million04/23/2024$4.25$4.38+3.06%$4.48$4.26362,141 shs$529.50 million04/22/2024$4.24$4.25+0.24%$4.38$4.18443,260 shs$513.78 million04/19/2024$4.36$4.24-2.75%$4.34$4.14368,960 shs$512.57 million04/18/2024$4.32$4.36+0.93%$4.49$4.27330,710 shs$527.08 million04/17/2024$4.25$4.32+1.65%$4.36$4.20430,378 shs$522.25 million04/16/2024$4.36$4.25-2.52%$4.40$4.17570,131 shs$513.78 million04/15/2024$4.66$4.36-6.34%$4.77$4.33551,770 shs$527.08 million04/12/2024$4.91$4.66-5.19%$4.87$4.61339,666 shs$562.74 million04/11/2024$4.76$4.91+3.26%$4.93$4.72407,494 shs$593.57 million04/10/2024$4.92$4.76-3.35%$5.03$4.70719,943 shs$574.83 million04/09/2024$4.97$4.92-0.91%$5.05$4.81440,160 shs$594.78 million04/08/2024$4.84$4.97+2.58%$5.03$4.78407,199 shs$600.20 million04/05/2024$4.97$4.84-2.62%$4.96$4.75413,375 shs$585.11 million04/04/2024$4.89$4.97+1.64%$5.13$4.91479,230 shs$600.81 million04/03/2024$5.21$4.89-6.05%$5.18$4.451.92 million shs$591.15 million04/02/2024$5.43$5.21-4.14%$5.40$5.16558,467 shs$629.23 million04/01/2024$5.72$5.43-5.07%$5.81$5.30526,893 shs$656.43 million03/29/2024$5.72$5.72$5.87$5.65504,653 shs$691.47 million03/28/2024$5.78$5.72-1.04%$5.87$5.65504,352 shs$691.49 million03/27/2024$5.74$5.78+0.70%$5.83$5.64312,709 shs$698.74 million03/26/2024$5.94$5.74-3.37%$5.99$5.73411,630 shs$693.91 million03/25/2024$6.06$5.94-1.98%$6.24$5.84509,372 shs$718.09 million03/22/2024$6.14$6.06-1.30%$6.29$5.95524,246 shs$732.59 million03/21/2024$6.86$6.14-10.50%$6.63$5.801.08 million shs$742.27 million03/20/2024$6.23$6.86+10.11%$6.88$6.12586,837 shs$829.31 million03/19/2024$6.38$6.23-2.35%$6.36$6.02341,299 shs$753.13 millionLook Who Fired the World’s Richest Man (Ad)This company is tiny… but already has contracts with 30 federal agencies and services some of the biggest companies in the U.S. And demand for the technology is unprecedented … “unlike anything we have seen in the past,” says a spokesman.Get the full story here.03/18/2024$6.60$6.38-3.33%$6.82$6.36491,168 shs$771.28 million03/15/2024$6.65$6.60-0.75%$6.85$6.414.56 million shs$797.87 million03/14/2024$6.78$6.65-1.92%$6.83$6.46875,756 shs$803.90 million03/13/2024$6.02$6.78+12.62%$6.83$6.001.32 million shs$819.63 million03/12/2024$5.53$6.02+8.86%$6.09$5.54783,335 shs$727.76 million03/11/2024$5.30$5.53+4.34%$5.88$5.37814,773 shs$668.52 million03/08/2024$5.43$5.30-2.39%$5.81$5.27472,971 shs$640.72 million03/07/2024$5.42$5.43+0.18%$5.69$5.30457,376 shs$656.43 million03/06/2024$5.87$5.42-7.67%$5.99$5.36753,119 shs$655.22 million03/05/2024$6.01$5.87-2.33%$6.05$5.79462,020 shs$709.61 million03/04/2024$6.52$6.01-7.82%$6.72$5.98698,931 shs$726.55 million03/01/2024$6.65$6.52-1.95%$6.83$6.50415,794 shs$788.20 million02/29/2024$6.72$6.65-1.04%$6.81$6.58561,195 shs$803.92 million02/28/2024$7.12$6.72-5.62%$7.20$6.53853,273 shs$812.38 million02/27/2024$6.85$7.12+3.94%$7.17$6.80671,711 shs$860.74 million02/26/2024$6.58$6.85+4.10%$6.96$6.64551,176 shs$828.10 million02/23/2024$6.84$6.58-3.80%$7.01$6.53509,332 shs$795.46 million02/22/2024$6.25$6.84+9.44%$6.90$6.30748,287 shs$826.89 million02/21/2024$6.37$6.25-1.88%$6.45$6.07419,492 shs$755.56 million02/20/2024$6.92$6.37-7.95%$7.04$6.24579,522 shs$770.05 million02/19/2024$6.92$6.92$7.20$6.73810,300 shs$836.56 million02/16/2024$6.74$6.92+2.67%$7.20$6.73809,425 shs$836.56 million02/15/2024$5.90$6.74+14.24%$6.92$6.101.77 million shs$814.78 million02/14/2024$5.80$5.90+1.81%$6.33$5.762.76 million shs$713.25 million02/13/2024$7.51$5.80-22.84%$7.27$5.793.50 million shs$700.56 million Related Companies: Cabaletta Bio Stock Chart Kyverna Therapeutics Stock Chart Novavax Stock Chart Humacyte Stock Chart Prime Medicine Stock Chart Valneva Stock Chart ProKidney Stock Chart HilleVax Stock Chart Alector Stock Chart Allogene Therapeutics Stock Chart Receive EXAI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Exscientia and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EXAI) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxHUGE BUY ALERT: Move Fast, Musk...Stansberry ResearchDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exscientia plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.